Clinical Trials Browser

Central Nervous System Neoplasms × Gemcitabine × Sarcoma × Clear all

NCT04521686 2025-06-27

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations

Phase 1 Active not recruiting

BreastCNSDermatologicGastrointestinalGenitourinaryHead & NeckSarcoma

Breast Neoplasms, Chondrosarcoma, Colonic Neoplasms, Glioblastoma, Glioma, Melanoma, Prostatic Neoplasms, Thyroid Neoplasms, Central Nervous System Neoplasms, Cholangiocarcinoma

NCT00407433 2009-08-07

Clinical Studies of Gemcitabine-Oxaliplatin

Phase 2 Completed

Medulloblastoma, Neuroblastoma, Osteosarcoma, Central Nervous System Neoplasms